Impact of spin-freezing parameters and excipient composition on product stability of a PEGylated peptide formulation.

Schaal, Zarah et al.·International journal of pharmaceutics·2025·Preliminary Evidencelaboratory study
RPEP-13449Laboratory studyPreliminary Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
laboratory study
Evidence
Preliminary Evidence
Sample
N=Not applicable (pharmaceutical formulation study)
Participants
PEGylated peptide formulations under various processing and storage conditions

What This Study Found

For a PEGylated peptide drug, the choice of sugar excipient (trehalose, mannitol, or sucrose-mannitol) had a far greater impact on stability than spin-freezing parameters. Trehalose gave the best stability. Sucrose-mannitol degraded badly at high temperature.

Key Numbers

Three formulations tested: trehalose, mannitol, sucrose-mannitol (75:25). Four spin-freezing conditions. Storage at 2-8°C or 50°C for up to 13 weeks. Sucrose-mannitol showed cake collapse, browning, and degradation at 50°C.

How They Did This

Compared trehalose, mannitol, and sucrose-mannitol formulations across four spin-freezing conditions. Evaluated peptide concentration, monomer content, and cake morphology after batch drying and accelerated/refrigerated storage.

Why This Research Matters

Continuous freeze-drying is a promising manufacturing method for peptide drugs. This study shows that formulation choice matters more than processing conditions for product stability.

What This Study Doesn't Tell Us

Single PEGylated peptide studied. Results may not generalize to all peptide drugs. 50°C is an accelerated stress condition, not normal storage.

Trust & Context

Original Title:
Impact of spin-freezing parameters and excipient composition on product stability of a PEGylated peptide formulation.
Published In:
International journal of pharmaceutics, 683, 126007 (2025)
Database ID:
RPEP-13449

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Cite This Study

RPEP-13449·https://rethinkpeptides.com/research/RPEP-13449

APA

Schaal, Zarah; Bockstal, Pieter-Jan Van; Lammens, Joris; Lenger, Julian H; Funke, Adrian P; Schneid, Stefan C; Beer, Thomas De. (2025). Impact of spin-freezing parameters and excipient composition on product stability of a PEGylated peptide formulation.. International journal of pharmaceutics, 683, 126007. https://doi.org/10.1016/j.ijpharm.2025.126007

MLA

Schaal, Zarah, et al. "Impact of spin-freezing parameters and excipient composition on product stability of a PEGylated peptide formulation.." International journal of pharmaceutics, 2025. https://doi.org/10.1016/j.ijpharm.2025.126007

RethinkPeptides

RethinkPeptides Research Database. "Impact of spin-freezing parameters and excipient composition..." RPEP-13449. Retrieved from https://rethinkpeptides.com/research/schaal-2025-impact-of-spinfreezing-parameters

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.